MODULE 1 ยท GDFM PROGRAMME

Eyelid Problems & Chronic Eye Conditions

๐Ÿ“… ๐Ÿ› College of Family Physicians Singapore

Learning Objectives

  • ๐Ÿ’Ž Identify and differentiate common benign and malignant eyelid lesions
  • ๐Ÿ’Ž Apply a systematic approach to preseptal vs orbital cellulitis
  • ๐Ÿ’Ž Diagnose and manage dry eye disease and epiphora in primary care
  • ๐Ÿ’Ž Investigate binocular diplopia and cranial nerve palsies
  • ๐Ÿ’Ž Screen and refer patients with refractive errors, cataracts, and AMD
  • ๐Ÿ’Ž Recognise ocular manifestations of systemic diseases

Benign Eyelid Lesions

  • ๐Ÿ’Ž Cyst of Moll โ€” blocked apocrine gland; dome-shaped, transilluminates (clear fluid)
  • ๐Ÿ’Ž Cyst of Zeis โ€” blocked sebaceous gland; yellow oily content, does NOT transilluminate
  • ๐Ÿ’Ž Chalazion โ€” granulomatous; painless nodule from blocked Meibomian duct
  • ๐Ÿ’Ž Molluscum contagiosum โ€” Poxviridae; refer to ophthalmologist to prevent follicular conjunctivitis
  • ๐Ÿšจ Red flags for malignancy: lid margin distortion, madarosis/poliosis, recurrent chalazion, ulceration, proptosis
Cyst of Moll (top-left), Cyst of Zeis (top-right), Chalazion (bottom-left), Molluscum contagiosum (bottom-right)

Cyst of Moll (top-left), Cyst of Zeis (top-right), Chalazion (bottom-left), Molluscum contagiosum (bottom-right)

Swollen Red Eyelid โ€” Preseptal vs Orbital Cellulitis

  • ๐Ÿ’Ž Preseptal cellulitis: infection ANTERIOR to orbital septum โ€” normal vision, pupils, and movements
  • ๐Ÿ’Ž Can be managed with oral antibiotics in reliable patients
  • ๐Ÿšจ Orbital cellulitis: infection POSTERIOR to septum โ€” MEDICAL EMERGENCY
  • ๐Ÿšจ Features: pain on eye movement, proptosis, diplopia, reduced VA
  • ๐Ÿšจ Immediate hospital referral for IV antibiotics and CT orbit
Diagnostic flowchart for swollen red eyelid evaluation and management

Diagnostic flowchart for swollen red eyelid evaluation and management

Dry Eye Disease โ€” Causes & Approach

  • ๐Ÿ’Ž Three mechanisms: altered tear production, blink reflex failure, underlying corneal disease
  • ๐Ÿ’Ž Sjรถgren's syndrome โ€” aqueous deficiency + xerostomia + autoimmune disease
  • ๐Ÿ’Ž Rosacea/blepharitis โ€” lipid layer abnormality (Meibomian gland dysfunction)
  • ๐Ÿ’Ž Parkinson's disease โ€” reduced blink frequency; Bell's palsy โ€” lagophthalmos
  • ๐Ÿ’Ž Treatment: preservative-free artificial tears QDS; doxycycline 50mg/day for rosacea-MGD
  • ๐Ÿ’Ž Failure to respond โ†’ refer for punctal plugs or cautery

Watery Eyes (Epiphora)

  • ๐Ÿ’Ž Three mechanisms: reflex overproduction (most common), lacrimal pump failure, nasolacrimal obstruction
  • ๐Ÿ’Ž Dry eye โ†’ reflex tearing โ€” paradoxical watery eye; treat the underlying dry eye
  • ๐Ÿ’Ž Ectropion / facial palsy โ†’ pump failure; surgical lid correction often required
  • ๐Ÿ’Ž Dacryocystitis โ€” pain/swelling medial canthus; oral antibiotics โ†’ refer for DCR
  • ๐Ÿšจ Congenital glaucoma โ€” watery eye + photophobia + enlarged cornea in infants = EMERGENCY
Lacrimal drainage anatomy and causes of epiphora with management flowchart

Lacrimal drainage anatomy and causes of epiphora with management flowchart

Diplopia โ€” Cranial Nerve Palsies

  • ๐Ÿ’Ž First step: monocular (ocular cause) vs binocular (neurological/muscular)
  • ๐Ÿ’Ž CN VI palsy โ€” horizontal diplopia worse at distance and on lateral gaze
  • ๐Ÿ’Ž CN IV palsy โ€” vertical diplopia; worse on downgaze; head tilt compensation
  • ๐Ÿ’Ž CN III palsy โ€” ptosis, large exotropia; pupil involvement indicates aneurysm
  • ๐Ÿšจ Painful CN III palsy + dilated pupil = posterior communicating artery aneurysm โ€” NEUROSURGICAL EMERGENCY
  • ๐Ÿšจ Headache + jaw claudication + CN palsy in elderly โ†’ Giant Cell Arteritis
Eye positions in different gaze directions for CN III, IV, and VI palsies

Eye positions in different gaze directions for CN III, IV, and VI palsies

Refractive Errors

  • ๐Ÿ’Ž Myopia (short-sighted) โ€” focus anterior to retina; concave lens; typically school-age onset
  • ๐Ÿ’Ž Hyperopia (long-sighted) โ€” focus posterior to retina; convex lens; risk of amblyopia if uncorrected
  • ๐Ÿ’Ž Astigmatism โ€” rugby-ball shaped cornea; blurred at all distances
  • ๐Ÿ’Ž Presbyopia โ€” universal age-related near vision loss from age ~40
  • ๐Ÿ’Ž Referral: VA < 6/9 in children, < 6/12 in adults, or 2-line difference between eyes
Diagram of emmetropia, myopia, hyperopia, and astigmatism with corrective lens effects

Diagram of emmetropia, myopia, hyperopia, and astigmatism with corrective lens effects

Myopia Control โ€” Atropine Update 2024

  • ๐Ÿ’Ž Low-dose atropine slows myopia progression and axial elongation in children
  • ๐Ÿ’Ž ATOM2 (Singapore): 0.01% โ€” minimal side effects, less rebound on cessation
  • ๐Ÿ’Ž LAMP 5-year trial (2024): 0.05% atropine superior for axial length control vs 0.01%
  • ๐Ÿ’Ž Most children required treatment restart after cessation at year 3
  • ๐Ÿ’Ž Current practice: 0.05% preferred for efficacy; 0.01% if minimising side effects is priority
  • ๐Ÿ’Ž Individualised decision-making recommended โ€” discuss with paediatric ophthalmologist

Refractive Surgery Options (2026)

  • ๐Ÿ’Ž PRK/Trans-PRK โ€” surface ablation; good for thin corneas; slower recovery
  • ๐Ÿ’Ž Bladeless LASIK โ€” femtosecond flap + excimer ablation; rapid recovery; risk of dry eye & ectasia
  • ๐Ÿ’Ž SMILE (NEW) โ€” lenticule extraction via small incision; no flap; better biomechanical stability; fewer dry eye symptoms
  • ๐Ÿ’Ž Phakic IOL (ICL) โ€” reversible; for high myopia beyond laser range
  • ๐Ÿ’Ž Clear Lens Exchange โ€” for presbyopia + high refractive error
  • ๐Ÿšจ Contraindications: keratoconus, unstable refraction, active infection, severe dry eye

Gradual Visual Loss โ€” Differential Diagnosis

  • ๐Ÿ’Ž Pinhole test: vision improves โ†’ likely refractive error
  • ๐Ÿ’Ž Absent red reflex โ†’ cataract (phacoemulsification + IOL when affecting QoL)
  • ๐Ÿ’Ž Asymptomatic disc cupping / field loss โ†’ POAG (refer for IOP and OCT)
  • ๐Ÿ’Ž Central vision loss + metamorphopsia + drusen โ†’ AMD (Amsler grid monitoring)
  • ๐Ÿšจ Bitemporal hemianopia โ†’ pituitary lesion
  • ๐Ÿšจ RAPD โ†’ unilateral optic nerve pathology

Age-Related Macular Degeneration (ARMD)

  • ๐Ÿ’Ž Dry AMD: drusen + geographic atrophy โ†’ gradual central vision loss
  • ๐Ÿ’Ž AREDS2 supplements (Vit C/E, lutein/zeaxanthin, zinc, copper) slow progression in intermediate-advanced dry AMD
  • ๐Ÿ’Ž 2024 Update: AREDS2 also slows geographic atrophy (late dry AMD) by ~55% over 3 years
  • ๐Ÿšจ Wet AMD: choroidal neovascularisation โ†’ sudden metamorphopsia โ†’ URGENT referral (within 1 week)
  • ๐Ÿšจ Treatment: intravitreal anti-VEGF (ranibizumab, aflibercept, faricimab)
  • ๐Ÿ’Ž Home Amsler grid monitoring to detect early conversion from dry to wet
Extensive macular drusen in dry AMD

Extensive macular drusen in dry AMD

Wet AMD vs Dry AMD

  • ๐Ÿ’Ž Dry AMD: gradual central blurring, drusen on fundoscopy, geographic atrophy
  • ๐Ÿ’Ž Wet AMD: acute/subacute central loss, metamorphopsia, subretinal fluid/haemorrhage
  • ๐Ÿ’Ž Refer Advanced dry AMD within 1 month; Suspected wet AMD within 1 WEEK
  • ๐Ÿ’Ž Intermediate AMD: annual screening; consider AMD care pathway
  • ๐Ÿšจ Any new metamorphopsia or sudden change in Amsler grid โ†’ urgent same-week referral
Disciform scar with subretinal haemorrhage in advanced wet AMD

Disciform scar with subretinal haemorrhage in advanced wet AMD

Diabetic Retinopathy โ€” Fundoscopy

  • ๐Ÿ’Ž Screen T2DM at diagnosis; T1DM within 5 years of diagnosis
  • ๐Ÿ’Ž NPDR: microaneurysms โ†’ dot/blot haemorrhages โ†’ cotton wool spots โ†’ hard exudates
  • ๐Ÿ’Ž PDR: neovascularisation at disc (NVD) or elsewhere (NVE) โ†’ vitreous haemorrhage
  • ๐Ÿ’Ž Diabetic macular oedema โ€” leading cause of vision loss in working-age adults; OCT diagnosis
  • ๐Ÿšจ PDR or M1 maculopathy โ†’ urgent ophthalmology referral
  • ๐Ÿšจ Good VA does NOT exclude sight-threatening retinopathy
Microaneurysms โ€” earliest fundoscopic sign of non-proliferative diabetic retinopathy

Microaneurysms โ€” earliest fundoscopic sign of non-proliferative diabetic retinopathy

Proliferative Diabetic Retinopathy

  • ๐Ÿ’Ž NVD (neovascularisation at disc) or NVE (elsewhere) = proliferative DR
  • ๐Ÿ’Ž Risk of vitreous haemorrhage and tractional retinal detachment
  • ๐Ÿ’Ž Treatment: pan-retinal photocoagulation (PRP) laser or intravitreal anti-VEGF
  • ๐Ÿšจ Urgent ophthalmology referral โ€” do not delay
  • ๐Ÿ’Ž Optimise glycaemic control, BP, and lipids to slow progression
Neovascularisation at the disc (NVD) โ€” hallmark of proliferative diabetic retinopathy

Neovascularisation at the disc (NVD) โ€” hallmark of proliferative diabetic retinopathy

The Eye in Systemic Disease

  • ๐Ÿ’Ž Thyroid Eye Disease: lid retraction, lid lag, proptosis, diplopia, compressive optic neuropathy
  • ๐Ÿ’Ž Uveitis (anterior): HLA-B27 spondyloarthropathies (AS), Behรงet's, JIA
  • ๐Ÿ’Ž Hypertensive retinopathy: AV nipping, flame haemorrhages, cotton wool spots, papilloedema
  • ๐Ÿ’Ž Kayser-Fleischer rings โ†’ Wilson's disease
  • ๐Ÿ’Ž CMV retinitis โ€” 'pizza pie' appearance in advanced immunocompromise
  • ๐Ÿšจ Scleritis โ€” severe boring pain + scleral oedema โ†’ often associated autoimmune disease
AV nipping at vessel crossing โ€” hypertensive retinopathy

AV nipping at vessel crossing โ€” hypertensive retinopathy

Glaucoma โ€” Optic Disc Cupping

  • ๐Ÿ’Ž Primary Open-Angle Glaucoma (POAG) โ€” chronic, insidious, often asymptomatic until late
  • ๐Ÿ’Ž Risk factors: family history, elevated IOP, older age, myopia, African ethnicity
  • ๐Ÿ’Ž Fundoscopy: increased cup-to-disc ratio (>0.6), asymmetry between eyes, disc notching
  • ๐Ÿ’Ž Visual field defects: arcuate scotoma, nasal step
  • ๐Ÿšจ Refer if C/D > 0.6, asymmetry โ‰ฅ 0.2, or suspicious disc regardless of IOP
  • ๐Ÿ’Ž Annual screening recommended for at-risk patients >40 years
Progressive cup-to-disc ratio enlargement from normal (0.2) to advanced glaucoma (0.99)

Progressive cup-to-disc ratio enlargement from normal (0.2) to advanced glaucoma (0.99)

Other Fundoscopy Findings

  • ๐Ÿ’Ž CRAO: cherry-red spot + pale retina + attenuated vessels โ†’ sudden painless visual loss
  • ๐Ÿ’Ž CRVO: disc swelling + tortuous dilated veins + flame haemorrhages in all 4 quadrants
  • ๐Ÿ’Ž Papilloedema: blurred disc margins + peripapillary haemorrhages โ†’ raised ICP until proven otherwise
  • ๐Ÿ’Ž Retinal detachment: pale elevated retinal folds โ†’ flashing lights + floaters + curtain visual loss
  • ๐Ÿšจ All of the above = SAME-DAY emergency ophthalmology referral
  • ๐Ÿ’Ž Retinitis pigmentosa: bone-spicule pigmentation + vessel attenuation + night blindness
Cherry-red spot at the macula with pale retina โ€” central retinal artery occlusion (CRAO)

Cherry-red spot at the macula with pale retina โ€” central retinal artery occlusion (CRAO)

Key Summary

Key Point
๐Ÿšจ Orbital cellulitis (pain on movement, proptosis, reduced VA) = immediate hospital referral
Key Point
๐Ÿšจ Painful CN III palsy + dilated pupil = aneurysm until proven otherwise โ€” neurosurgical emergency
Key Point
๐Ÿšจ New metamorphopsia / sudden central vision change = wet AMD โ€” refer within 1 WEEK
Key Point
๐Ÿ’Ž Dry eye: artificial tears QDS; doxycycline for rosacea-MGD; refer if persistent
Key Point
๐Ÿ’Ž DR screening: T2DM at diagnosis; T1DM within 5 years โ€” good VA does NOT exclude PDR
Key Point
๐Ÿ’Ž Myopia control: 0.05% atropine superior efficacy (LAMP 2024); 0.01% if SE minimisation preferred

Key References

  • Sun MT et al. Eyelid lesions in general practice. Aust J Gen Pract. 2019;48(8):509-514.
  • Carlisle RT, Digiovanni J. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2015;92(2):106-12.
  • Yam JC et al. LAMP 5-year trial โ€” 0.05% atropine for myopia. Ophthalmology. 2024 Mar.
  • Keenan TDL et al. AREDS2 slows geographic atrophy. Ophthalmology. 2024 Jul.
  • SIDRP โ€” SERI-NHGEI AMD Referral Criteria Guidelines (local Singapore guidelines).
  • Cochrane GM et al. Management of refractive errors. BMJ. 2010;340:c1171.